tiprankstipranks
pc:myosi

Myosin Therapeutics Inc

130 Scripps Way Jupiter, FL 33458, US
https://www.myosintherapeutics.com/
Myosin Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for cancer and neurological disorders. The company is advancing its lead compound, MT-125, designed to treat glioblastoma by targeting a molecular nanomotor to inhibit tumor growth and invasion. The FDA has granted orphan drug designation to MT-125 for malignant gliomas, highlighting its potential to significantly improve patient outcomes.

Leadership & Board

Current Number of Employees9
Current LinkedIn Followers876

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$8M
Total Amount Raised$8M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Employee Trend

Myosin Therapeutics Inc had 9 employees as of April 13, 2026. The number of employees increased by 0 (0.00%) week-over-week.
9Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Myosin Therapeutics Inc had 876 followers as of April 13, 2026. The number of followers increased by 7 (0.81%) week-over-week.
876Latest Followers Count
7(0.81%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 19, 2025
Investment
$4.50M
Mar 03, 2025
Seed Round
$3.00M

Investors

Investor Name
Funding Round

Related News and Analysis